NCT06552624

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers

An Open-label, Randomized, Crossover Study to Investigate the Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Valenta Pharm JSC · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Comparative study of the pharmacodynamic parameters and pharmacodynamic equivalence (bioequivalence) of drug Antareit 800 mg chewable tablets and drug Riopan 800 mg chewable tablets in healthy volunteers.

Conditions

• Heartburn
• Acid-dependent Diseases of the Gastrointestinal Tract
• Symptomatic Treatment of Gastric and Duodenal Ulcers

Interventions

Type	Name	Description
DRUG	Magaldrate	A dose of T drug in one of 2 periods of the study 2 h prior to food intake, 3 times per day
DRUG	Magaldrate	A dose of R drug in one of 2 periods of the study 2 h prior to food intake, 3 times per day

Timeline

• Start date: 2021-07-07
• Primary completion: 2022-08-31
• Completion: 2022-08-31
• First posted: 2024-08-14
• Last updated: 2024-08-14

Locations

3 sites across 1 country: Russia